GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Komipharm International Co 041960.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

8,570

+0.23%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩52.47bn

FY2016FY2025

Net income

−₩7.21bn

FY2016FY2025

Free cash flow

−₩5.09bn

FY2016FY2025

Shareholders' equity

₩69.54bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩52.47bn₩58.78bn₩42.65bn₩39.80bn₩35.85bn₩37.16bn₩35.49bn₩34.99bn₩36.64bn₩37.64bn
Research and development₩1.63bn₩2.47bn₩5.94bn₩2.54bn₩5.12bn₩3.27bn₩4.65bn₩2.76bn₩40.8m₩152.4m
Operating income₩1.96bn₩4.96bn−₩6.37bn−₩5.49bn−₩5.29bn−₩2.57bn−₩5.43bn−₩17.47bn−₩10.03bn−₩10.8m
Net income−₩7.21bn₩13.11bn−₩3.98bn−₩6.51bn−₩4.46bn−₩2.82bn−₩21.36bn−₩14.30bn−₩5.10bn₩289.4m
Diluted earnings per share-100.29189.28-56.72-92.84-63.41-44.07-335.76-224.95-80.504.60

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩133.92bn₩122.77bn₩118.60bn₩111.75bn₩115.26bn₩121.91bn₩125.64bn₩139.90bn₩149.27bn₩149.84bn
Cash and short-term investments———₩10.80bn₩13.93bn₩17.11bn₩20.92bn₩22.19bn₩27.59bn₩27.87bn
Total liabilities₩61.86bn₩57.23bn₩58.58bn₩51.12bn₩48.80bn₩45.64bn₩52.37bn₩46.52bn₩48.00bn₩56.64bn
Debt₩6.81bn₩8.90bn₩4.33bn₩38.13bn₩33.42bn₩35.67bn₩40.90bn₩36.07bn₩37.31bn₩45.34bn
Shareholders' equity₩69.54bn₩62.28bn₩56.34bn₩60.63bn₩66.46bn₩76.28bn₩73.28bn₩93.39bn₩101.27bn₩93.20bn
Shares outstanding72m69m70m70m70m64m64m64m63m63m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩621.8m₩8.85bn−₩2.80bn−₩1.81bn−₩1.26bn₩25.2m₩950.8m−₩2.02bn₩235.6m₩1.21bn
Capital spending−₩4.47bn−₩3.98bn−₩1.13bn−₩1.07bn−₩813.4m−₩1.66bn−₩5.74bn−₩5.43bn−₩2.68bn−₩12.24bn
Free cash flow−₩5.09bn₩4.87bn−₩3.93bn−₩2.87bn−₩2.07bn−₩1.63bn−₩4.79bn−₩7.45bn−₩2.44bn−₩11.03bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩16.70bn₩11.94bn₩11.90bn₩12.48bn₩13.68bn₩14.41bn₩15.73bn₩10.99bn
Operating income₩849.9m₩1.03bn—₩65.7m₩1.63bn₩509.1m—₩896.8m
Net income₩618.4m₩857.3m−₩3.91bn−₩150.5m−₩3.20bn₩46.8m₩761.4m₩6.49bn
Diluted earnings per share8.6011.93-54.36-2.10-45.020.6810.9993.71
Cash from operations₩1.73bn−₩1.52bn₩946.0m−₩178.0m−₩474.0m−₩915.0m₩8.85bn₩5.76bn
Capital spending−₩534.0m−₩1.03bn−₩1.85bn−₩1.29bn−₩1.03bn−₩297.0m−₩3.98bn−₩2.92bn
Free cash flow₩1.20bn−₩2.54bn−₩904.0m−₩1.47bn−₩1.51bn−₩1.21bn₩4.87bn₩2.84bn
Total assets₩139.12bn₩134.43bn₩133.92bn₩133.65bn₩121.67bn₩122.77bn₩122.77bn₩132.56bn
Cash and short-term investments—————₩21.01bn—₩27.46bn
Debt₩7.69bn₩6.81bn₩6.81bn₩15.20bn₩9.78bn₩30.42bn₩8.90bn₩31.11bn
Shareholders' equity₩71.69bn₩70.81bn₩69.54bn₩71.99bn₩67.95bn₩62.39bn₩62.28bn₩65.36bn

Financial ratios

Data as of 31 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin3.7%8.4%-14.9%-13.8%-14.8%-6.9%———
Net margin-13.7%22.3%-9.3%-16.4%-12.4%-7.6%———
Return on equity-10.4%21.1%-7.1%-10.7%-6.7%-3.7%———
Return on assets-5.4%10.7%-3.4%-5.8%-3.9%-2.3%———
Free cash flow yield——————1.1%0.6%0.5%
Revenue growth-10.7%37.8%7.2%11.0%-3.5%4.7%———
Earnings growth-155.0%-429.6%-38.9%46.1%58.4%-86.8%———
Current ratio1.30x1.30x0.96x1.04x1.61x1.14x———
Debt to equity0.10x0.14x0.08x0.41x0.49x0.27x———
Equity ratio51.9%50.7%47.5%54.3%57.7%62.6%———
Interest coverage0.75x1.55x-2.50x-2.48x-3.19x-1.66x———
R&D as a share of sales3.1%4.2%13.9%6.4%14.3%8.8%———
Buybacks as a share of market value——————-0.1%-0.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.6%7.1%3.7%
Net income3.4%20.7%1.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin6.2%-2.6%-4.8%-10.5%
Net margin5.3%-2.4%-4.4%-13.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-70.020.4-73.9-68.4-123.1-277.3-41.3-74.5-373.8—
Price to sales9.64.56.911.215.321.024.830.552.046.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Dec 2003.

FY2004FY2003FY2002
Paid in the year18.4546.15112.302
  • 798-for-725 split · 17 Aug 2023
  • 11-for-10 split · 11 Jul 2019
  • 21-for-20 split · 27 Dec 2018
  • 5-for-1 split · 13 May 2011
  • 1.194-for-1 split · 27 Dec 2007
  • 21-for-20 split · 28 Dec 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.